Tag: superficial femoral artery

Cook Medical receives FDA approval for first 5mm diameter SFA drug-eluting...

Cook Medical have announced that a new 5mm diameter version of Zilver PTX was approved by the US Food and Drug Administration (FDA). It...

IN.PACT Admiral DCB launched in Japan

Medtronic plc has announced the full commercial launch of the IN.PACT Admiral drug-coated balloon (DCB) in Japan. The launch follows the completion of a...

DETOUR I 12-month data show promising durability of bypass system

Results from the DETOUR I trial evaluating the DETOUR System (PQ Bypass) for percutaneous bypass showed promising 12-month durability for patients with extremely long...

LINC 2018 data highlight IN.PACT Admiral as safe and effective treatment...

Medtronic added to its body of clinical evidence supporting the IN.PACT Admiral drug-coated balloon with new presentations that demonstrated durable and consistent clinical outcomes...

Positive results for Boston Scientific Ranger paclitaxel-coated PTA balloon catheter

Positive results from the RANGER SFA trial for Boston Scientific’s Ranger paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter have been presented at the 2017...

Leaving nothing behind: Is it time to move away from primary...

This educational supplement is only available in countries in Europe. This educational supplement explores the concept of “leaving nothing behind" in the treatment of the superficial...

Medtronic launches European below-the-knee clinical study of drug-coated balloon

Medtronic has launched the IN.PACT BTK study to evaluate the effectiveness of using a drug-coated balloon in patients with below-the-knee (BTK) peripheral artery disease. This...

TIGRIS trial finds no stent fractures and positive primary patency in...

Twenty-four month TIGRIS trial follow-up data show that treatment using the Tigris nitinol stent (Gore) for long lesions in the superficial femoral and popliteal...

QT Vascular announces FDA approval to initiate pivotal trial of Chocolate...

The US Food and Drug Administration (FDA) has granted QT Vascular conditional Investigational Device Exemption (IDE) approval, allowing the company to begin enrolling patients...

Gore Viabahn endoprosthesis celebrates 20 years since introduction

Gore is celebrating the 20th anniversary of the introduction of the Viabahn endoprosthesis; its stent graft for the treatment of complex peripheral vascular disease....